Search

Celldex Therapeutics Inc

Закрыт

СекторЗдравоохранение

31.03 -1.37

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

30.28

Макс.

33.49

Ключевые показатели

By Trading Economics

Доход

5.2M

-74M

Продажи

7K

22K

Прибыль на акцию

-0.94

Рентабельность продаж

-334,104.545

Сотрудники

198

EBITDA

5.2M

-73M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+105.66% upside

Дивиденды

By Acuity

Следующий отчет о доходах

6 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

17M

3B

Предыдущая цена открытия

32.4

Предыдущая цена закрытия

31.03

Новостные настроения

By Acuity

20%

80%

25 / 339 Рейтинг в Healthcare

Celldex Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

23 сент. 2026 г., 20:02 UTC

News
Social Media

Celldex Therapeutics shares fell sharply amid safety concerns from its Phase 3 CSU study, despite Overweight ratings from Morgan Stanley and Leerink Partners.

22 сент. 2026 г., 23:06 UTC

Celldex Therapeutics Inc is seeing a modest increase in after-market trading, recovering from an earlier session low and gaining since Tuesday's close.

21 сент. 2026 г., 20:01 UTC

Celldex Therapeutics Inc shares fell sharply, diverging from recent gains as the biotechnology sector shows varied performance.

18 сент. 2026 г., 20:02 UTC

Celldex Therapeutics Inc shares fell sharply, remaining well below their 20-day moving average after a notable high earlier in the session.

17 сент. 2026 г., 20:07 UTC

Correlated Moves

Celldex Therapeutics Inc is modestly higher in Thursday's session, rebounding from an earlier pullback, amid a boost from positive developments in the biotech sector.

16 сент. 2026 г., 20:10 UTC

Celldex Therapeutics Inc is advancing in Wednesday's market session, showing modest gains since Tuesday, despite pulling back from earlier session highs.

15 сент. 2026 г., 20:07 UTC

Correlated Moves

Celldex Therapeutics Inc shares are lower amid sector-wide weakness in biotechnology, influenced by rising yields and Federal Reserve concerns.

14 сент. 2026 г., 20:03 UTC

Celldex Therapeutics Inc shares are higher today, with no specific news identified. Rising crude oil prices contribute to broader market inflation concerns ahead of the Fed's decision.

11 сент. 2026 г., 20:08 UTC

Celldex Therapeutics Inc shares are lower today, continuing a five-session decline. The stock is trading significantly below its 20-day moving average.

10 сент. 2026 г., 19:26 UTC

Correlated Moves

Celldex Therapeutics Inc shares are lower, reflecting bearish sentiment in the biotechnology sector. The stock remains below its 20-day moving average.

8 сент. 2026 г., 20:07 UTC

Celldex Therapeutics Inc shares are lower today, reflecting ongoing performance weakness amid speculation about a potential Federal Reserve interest rate hike.

28 авг. 2026 г., 20:03 UTC

Celldex Therapeutics Inc. shares are lower today, breaking a trend of higher closes. Broader market conditions may be influencing this shift.

24 авг. 2026 г., 20:06 UTC

Celldex Therapeutics is trading higher, reflecting positive sentiment in the biotechnology sector despite no specific company news. Overall movement remains higher since Friday's close.

21 авг. 2026 г., 19:26 UTC

Celldex Therapeutics Inc. shares are higher, maintaining above the 20-day moving average amid a broader market rebound and shifts toward safe-haven assets.

20 авг. 2026 г., 20:01 UTC

Celldex Therapeutics shares are lower as biotechnology stocks face pressure, reflecting a notable decline since Wednesday. Earlier, shares briefly peaked before dropping sharply.

19 авг. 2026 г., 19:26 UTC

Celldex Therapeutics Inc is trading higher during Wednesday's session, maintaining gains since Tuesday's close despite earlier intraday fluctuations.

18 авг. 2026 г., 19:36 UTC

Celldex Therapeutics Inc. shares are lower today amid broader market concerns, including rising treasury yields and inflation fears, despite remaining above the 20-day moving average.

17 авг. 2026 г., 19:16 UTC

Celldex Therapeutics Inc. shares are lower today, retracing from earlier gains amid broader market concerns over economic growth following recent U.S. retail sales data.

14 авг. 2026 г., 20:06 UTC

Celldex Therapeutics Inc shares are lower today amid mixed market sentiment following a decline in U.S. retail sales for July.

13 авг. 2026 г., 20:06 UTC

Celldex Therapeutics shares are lower today, continuing a decline since Wednesday amid rising initial jobless claims in the U.S.

12 авг. 2026 г., 19:56 UTC

Celldex Therapeutics Inc is higher today, maintaining a positive trend after closing up in the last seven sessions. The stock pulled back slightly from an earlier peak.

11 авг. 2026 г., 20:06 UTC

Celldex Therapeutics Inc shares are higher today, marking six consecutive sessions of gains. The stock remains significantly above its 20-day moving average.

10 авг. 2026 г., 19:16 UTC

News

Celldex Therapeutics shares are higher as Barclays and Morgan Stanley raise price targets to $53.00 and $46.00, respectively, maintaining overweight ratings.

7 авг. 2026 г., 19:11 UTC

News

Celldex Therapeutics shares are lower despite Morgan Stanley and Barclays raising price targets to $46 and $53, respectively. Broader market volatility persists.

5 авг. 2026 г., 20:01 UTC

Celldex Therapeutics Inc shares are trading higher amid a positive market backdrop, supported by declining oil prices and optimism over U.S.-Iran negotiations.

4 авг. 2026 г., 19:56 UTC

Celldex Therapeutics Inc shares are higher today, supported by overall market strength amid a decline in crude oil prices. No specific company news was identified.

3 авг. 2026 г., 19:53 UTC

Celldex Therapeutics Inc. shares are lower as biotechnology stocks decline. The broader sector's weakness has influenced the stock's price action today.

31 июл. 2026 г., 19:36 UTC

Celldex Therapeutics Inc. shares are lower today amid significant pressure on biotechnology stocks, with no specific company news identified to explain the decline.

30 июл. 2026 г., 18:51 UTC

Celldex Therapeutics Inc is advancing during Thursday's session, moving higher alongside the broader market amid positive macroeconomic sentiment.

29 июл. 2026 г., 20:03 UTC

Macro Event
News

Wells Fargo raised its price target on Celldex Therapeutics to $72, citing confidence in the company's growth prospects and promising pipeline. Shares are higher today.

Сравнение c конкурентами

Изменение цены

Celldex Therapeutics Inc Прогноз

Целевая цена

By TipRanks

105.66% рост

Прогноз на 12 месяцев

Средняя 64 USD  105.66%

Максимум 100 USD

Минимум 28 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Celldex Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

12 ratings

11

Покупка

1

Удержание

0

Продажа

Настроения

By Acuity

25 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.